Superbugs resistant to all antibiotics

Value of human life is always eclipsed by the concern of profit. No pharmaceutical companies have done serious R&D on the new antibiotics to attack the two superbugs, NDM-1 and KPC. In 2011, KPC bacteria killed 12 patients inside the state-of-the-art NIH clinical center in Maryland, USA. NDM-1 and KPC are still lurking all around the whole world and prepare to launch another bout of outbreak.   http://www.pbs.org/wgbh/pages/frontline/hunting-the-nightmare-bacteria/